• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Evofem Biosciences released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 4.952 M, actual EPS USD -0.014
04:00
Evofem Biosciences released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 10.62 M, actual EPS USD -0.0338
04:00
Aug15
Evofem Biosciences released FY2025 Semi-Annual Earnings on August 14 (EST), actual revenue USD 5.67 M, actual EPS USD -0.0099
03:00
Evofem Biosciences released FY2025 Q2 earnings on August 14, 2025 (EST), with actual revenue of USD 4.825 M and EPS of USD -0.0199
03:00
Jul2
Evofem Signs $1.4M Agreement with Aditxt
20:15
Jun23
Evofem and Pharma 1 Submit PHEXXI® Regulatory Application
12:47

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.952 M, Net Income -1.68 M, EPS -0.014

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.825 M, Net Income -1.785 M, EPS -0.0199

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 845 K, Net Income 953 K, EPS 0.0001

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More